Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 63 Observational 1

Sponsor

Cancer Type

Gastrointestinal 4 CNS 2 Thoracic 1 Breast 1

Conditions

Lung Neoplasms 1

Interventions

Blood Specimen Collection 53 Surveys and Questionnaires 30 Drug Therapy 27 Immunotherapy 25 Surgical Procedures, Operative 22 Carboplatin 22 Nivolumab 21 Immune Checkpoint Inhibitors 20 pembrolizumab 18 osimertinib 18 atezolizumab 17 Observation 17 Radiotherapy 16 Bevacizumab 15 Cisplatin 14 Afatinib 14 Specimen Handling 13 Gene Expression Profiling 13 Erlotinib Hydrochloride 13 lorlatinib 12 Pemetrexed 12 Magnetic Resonance Spectroscopy 11 Ipilimumab 11 Immunohistochemistry 11 Biopsy 11 durvalumab 10 alectinib 10 Paclitaxel 10 Bronchoscopy 10 Tomography, X-Ray Computed 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × apatinib × Thoracic × Clear all

NCT03376191 2017-12-18

Apatinib in Advanced Non-squamous，NSCLC

Peking University Cancer Hospital & Institute

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡